The choice between peptides depends on individual goals, tolerance, health status, and whether broad metabolic effects or selective fat targeting is preferred
Animal studies show significant improvements in body composition, metabolic markers, and muscle function with minimal adverse effects
This stack maximizes appetite suppression rather than combining appetite control with targeted lipolysis
Not recommended for those with sensitive skin
Because AOD9604 does not stimulate IGF-1 production and lacks strong GH receptor agonism, it may present a safer alternative for long-term OA treatment [1]
Preclinical literature frequently references cellular and animal models involving endocrine regulation, metabolic signaling, and hormone secretion dynamics when examining Tesamorelin